Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Acta Crystallographica. Section E, Structure Reports Online|March 12, 2013
{[(1Z)-3-Chloro-1H-isoindol-1-yl-idene]meth-yl}dimethyl-amineZhao-Yun Wang, Chang-Jiang Yu
Huan Jing Ke Xue= Huanjing Kexue|July 13, 2018
[Preparation and Characterization of a Calcium Alginate/Biochar Microsphere and Its Adsorption Characteristics and Mechanisms for Pb(Ⅱ)]Chang-Jiang Yu, Xin-Yu Dong, Miao Wang, et al.
Cellular Immunology|April 11, 2021
Application of mesenchymal stem cell-derived exosomes in kidney diseasesDeng Gang, Chang Jiang Yu, Shuoji Zhu, et al.
Frontiers in Immunology|October 11, 2021
Tryptophan Catabolism and Inflammation: A Novel Therapeutic Target For Aortic DiseasesTharmarajan Ramprasath, Young-Min Han, Donghong Zhang, et al.
Biochemistry and Biophysics Reports|October 27, 2025
Smooth muscle cell (SMC)-Specific SNRK deletion in mouse causes congenital short bowel syndrome and premature deathChang-Jiang Yu, Liu Ouyang, Junqing An, et al.
Biochemistry and Biophysics Reports|March 23, 2026
Corrigendum to "Smooth muscle cell (SMC) Specific SNRK deletion in mouse causes congenital short bowel syndrome and premature death" [Biochem. Biophys. Rep. 44 (2025) 102298]Chang-Jiang Yu, Liu Ouyang, Junqing An, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|November 29, 2017
[Surgical management of pregnancy-associated acute Stanford type A aortic dissection: analysis of 5 cases]Xin Li, Hong-Yu Zhang, Feng-Zhen Han, et al.
Regenerative Medicine Research|May 19, 2015
Endothelial progenitor cells in cardiovascular diseases: from biomarker to therapeutic agentHui-Bin Liu, Yuan-Feng Gong, Chang-Jiang Yu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 7, 2024
Blocking CTLA-4 promotes pressure overload-induced heart failure via activating Th17 cellsAn-Qi Shang, Chang-Jiang Yu, Xin Bi, et al.
Heliyon|September 25, 2024
Inhibition of CTLA-4 accelerates atherosclerosis in hyperlipidemic mice by modulating the Th1/Th2 balance via the NF-κB signaling pathwayMing-Luan Zhao, Chen Liang, Wei-Wei Jiang, et al.
Pageof 3